Seq |
Description |
Document |
Type |
Size |
1 |
CURRENT REPORT |
ea0213193-8k_orukathera.htm iXBRL |
8-K |
297575 |
2 |
CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF |
ea021319301ex3-1_oruka.htm |
EX-3.1 |
7601 |
3 |
CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF |
ea021319301ex3-2_oruka.htm |
EX-3.2 |
7602 |
4 |
CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF |
ea021319301ex3-3_oruka.htm |
EX-3.3 |
6489 |
5 |
CERTIFICATE OF AMENDMENT TO AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF |
ea021319301ex3-4_oruka.htm |
EX-3.4 |
8875 |
6 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF THE COMPANY, FILED SEPTEMBE |
ea021319301ex3-5_oruka.htm |
EX-3.5 |
26746 |
7 |
AMENDED AND RESTATED BYLAWS OF THE COMPANY |
ea021319301ex3-6_oruka.htm |
EX-3.6 |
152087 |
8 |
FORM OF CERTIFICATE OF ELIMINATION OF CERTIFICATE OF DESIGNATION OF PREFERENCES, |
ea021319301ex3-8_oruka.htm |
EX-3.8 |
9386 |
9 |
FORM OF CERTIFICATE OF DESIGNATION OF PREFERENCES, RIGHTS AND LIMITATIONS OF SER |
ea021319301ex3-9_oruka.htm |
EX-3.9 |
71073 |
10 |
ORUKA THERAPEUTICS, INC. 2024 STOCK INCENTIVE PLAN |
ea021319301ex10-10_oruka.htm |
EX-10.10 |
113469 |
11 |
ORUKA THERAPEUTICS, INC. 2024 EMPLOYEE STOCK PURCHASE PLAN |
ea021319301ex10-11_oruka.htm |
EX-10.11 |
82081 |
12 |
SECOND AMENDMENT TO AMENDED AND RESTATED ORUKA THERAPEUTICS, INC. 2024 EQUITY IN |
ea021319301ex10-13_oruka.htm |
EX-10.13 |
11652 |
13 |
FORM OF EMPLOYEE WARRANT AGREEMENT |
ea021319301ex10-16_oruka.htm |
EX-10.16 |
34388 |
14 |
CONSULTING AGREEMENT, EFFECTIVE AS OF AUGUST 30, 2024, BY AND BETWEEN ORUKA THER |
ea021319301ex10-25_oruka.htm |
EX-10.25 |
76344 |
15 |
CODE OF BUSINESS CONDUCT AND ETHICS OF ORUKA THERAPEUTICS, INC |
ea021319301ex14-1_oruka.htm |
EX-14.1 |
86667 |
16 |
LETTER FROM KPMG LLP, DATED SEPTEMBER 5, 2024 |
ea021319301ex16-1_oruka.htm |
EX-16.1 |
2741 |
17 |
LIST OF SUBSIDIARIES OF ORUKA THERAPEUTICS, INC |
ea021319301ex21-1_oruka.htm |
EX-21.1 |
2260 |
18 |
PRESS RELEASE, ISSUED ON SEPTEMBER 3, 2024 |
ea021319301ex99-1_oruka.htm |
EX-99.1 |
12993 |
19 |
AUDITED FINANCIAL STATEMENT OF ORUKA THERAPEUTICS, INC. AS OF FEBRUARY 6, 2024 |
ea021319301ex99-2_oruka.htm |
EX-99.2 |
52736 |
20 |
UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS OF ORUKA THERAPEUT |
ea021319301ex99-3_oruka.htm |
EX-99.3 |
231546 |
21 |
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERA |
ea021319301ex99-4_oruka.htm |
EX-99.4 |
150801 |
22 |
UNAUDITED PRO FORMA FINANCIAL STATEMENTS OF ORUKA THERAPEUTICS, INC. AND ARCA BI |
ea021319301ex99-5_oruka.htm |
EX-99.5 |
244728 |
23 |
GRAPHIC |
ex14-1_001.jpg |
GRAPHIC |
6156 |
|
Complete submission text file |
0001213900-24-076184.txt |
|
2261549 |